海隆控股(01623.HK)擬交換未償還1.65億美元2020年到期7.25%優先票據
格隆匯5月20日丨海隆控股(01623.HK)宣佈,於2020年5月20日,公司就身處美國境外的非美國籍人士持有的公司尚未償還於2020年到期的約1.65億美元7.25釐優先票據展開交換要約。
公司正在進行一項發行及出售額外新票據的獨立同步發售項目。同步新資金髮行能否完成須視乎市況而定。鍾港、中信里昂證券、滙豐及浦銀國際正就同步新資金髮行擔任聯席全球協調人、聯席賬簿管理人及聯席牽頭經辦人。
倘實行同步新資金髮行,公司將會把同步新資金髮行的現金所得款項淨額主要用於對其現有境外債務進行再融資,及任何餘額用作營運資金及一般公司用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.